C. A. Mccannel, G. N. Holland, and C. J. Helm, Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group, Am J Ophthalmol, vol.121, pp.35-46, 1996.

J. E. Reuland, M. S. Mackensen, and F. , Uveitis Subtypes in a German Interdisciplinary Uveitis Center-Analysis of 1916 Patients, J Rheumatol, vol.36, pp.127-163, 2009.

D. A. Brewerton, M. Caffrey, and A. Nicholls, Acute anterior uveitis and HLA B27, Lancet, vol.2, issue.7836, pp.994-1000, 1973.

D. A. Brewerton, F. D. Hart, and A. Nicholls, Ankylosing spondylitis and HLA B27, Lancet, vol.1, issue.73, pp.91360-91363, 1973.

J. H. Chang, P. J. Mccluskey, and W. D. , Acute anterior uveitis and HLA-B27, Surv Ophthalmol, vol.50, pp.364-88, 2005.

N. Zeboulon, M. Dougados, and . Gossec, Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review, Ann Rheum Dis, vol.67, pp.955-959, 2008.

J. Wach, D. Maucort-boulch, L. Kodjikian, C. Broussolle, and P. Sève, Acute anterior uveitis and undiagnosed spondyloarthritis: usefulness of Berlin criteria, Graefes Arch Clin Exp Ophthalmol, vol.253, issue.1, p.25142374, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02018999

D. Monnet, M. Breban, and C. Hudry, Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases, Ophthalmology, vol.111, pp.802-811, 2004.

E. B. Suhler, T. M. Martin, and J. T. Rosenbaum, HLA-B27-associated uveitis: overview and current perspectives, Curr Opin Ophthalmol, vol.14, pp.378-83, 2003.

J. P. Dunn, Review of immunosuppressive drug therapy in uveitis, Curr Opin Ophthalmol, vol.15, pp.293-298, 2004.

J. A. Dunne, N. Jacobs, A. Morrison, and D. J. Gilbert, Efficacy in anterior uveitis of two known steroids and topical tolmetin, Br J Ophthalmol, vol.69, pp.120-125, 1985.

P. A. Gaudio, A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation, Ocul Immunol Inflamm, vol.12, pp.169-192, 2004.

D. A. Jabs, J. T. Rosenbaum, C. S. Foster, G. N. Holland, G. J. Jaffe et al., Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders, Am J Ophthalmol, vol.130, pp.492-513, 2000.

J. M. Benitez-del-castillo, J. Garcia-sanchez, T. Iradier, and A. Banares, Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis, Eye, vol.14, pp.340-343, 2000.

S. Muñoz-ferná-ndez, V. Hidalgo, J. Fernández-meló-n, A. Schlincker, G. Bonilla et al., Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period, J Rheumatol, vol.30, issue.6, pp.1277-1286, 2003.

S. Muñoz-ferná-ndez, A. M. García-aparicio, M. V. Hidalgo, M. Platero, A. Schlincker et al., Methotrexate: an option for preventing the recurrence of acute anterior uveitis, Eye, vol.23, issue.5, pp.1130-1133, 2008.

J. Braun, X. Baraliakos, J. Listing, and J. Sieper, Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept, Arthritis & Rheumatism, vol.52, issue.8, pp.2447-51, 2005.

S. Guignard, L. Gossec, C. Salliot, A. Ruyssen-witrand, M. Luc et al., Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study, Ann Rheum Dis, vol.65, issue.12, pp.1631-1635, 2006.

M. Rudwaleit, E. Rødevand, P. Holck, J. Vanhoof, M. Kron et al., Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study, Ann Rheum Dis, vol.68, issue.5, pp.696-701, 2008.

M. Kim, J. Won, S. Y. Choi, J. H. Ju, and Y. Park, Anti-TNF? Treatment for HLA-B27-Positive Ankylosing Spondylitis-Related Uveitis, American Journal of Ophthalmology, vol.170, pp.32-40, 2016.

D. Wendling, J. Paccou, J. Berthelot, R. Flipo, S. Guillaume-czitrom et al., New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases, Semin Arthritis Rheum, vol.41, issue.3, pp.503-513, 2011.

V. Calvo-río, R. Blanco, M. Santos-gómez, E. Rubio-romero, M. Cordero-coma et al., Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients, Semin Arthritis Rheum, vol.46, issue.1, pp.95-101, 2016.

S. Yazgan, U. Celik, M. I??k, N. K. Ye?il, . Baki et al., Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis, Int Ophthalmol, vol.37, issue.1, p.27154720, 2017.

D. Van-der-heijde, R. S. Landewé, R. Baraliakos, X. Van-den-bosch, F. Sepriano et al., 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis, Ann Rheum Dis, vol.76, issue.6, pp.978-91, 2017.

M. Dougados, S. Van-der-linden, R. Juhlin, B. Huitfeldt, B. Amor et al., The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy, Arthritis Rheum, vol.34, issue.10, pp.1218-1245, 1991.

M. Rudwaleit, D. Van-der-heijde, R. Landewé, J. Listing, N. Akkoc et al., The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection, Ann Rheum Dis, vol.68, issue.6, pp.777-83, 2009.

M. Rudwaleit, D. Van-der-heijde, R. Landewé, N. Akkoc, J. Brandt et al., The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general, Ann Rheum Dis, vol.70, issue.1, pp.25-31, 2011.

D. A. Jabs, R. B. Nussenblatt, and J. T. Rosenbaum, Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop, Am J Ophthalmol, vol.140, pp.509-516, 2005.

M. Dougados, F. Berenbaum, A. Maetzel, and B. Amor, Prevention of acute anterior uveitis associated with spondylarthropathy induced by salazosulfapyridine, Rev Rhum Ed Fr, vol.60, issue.1, pp.81-84, 1993.

M. M. Zu-hoerste, K. Walscheid, C. Tappeiner, B. Zurek-imhoff, C. Heinz et al., The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a retrospective cohort study, Graefes Arch Clin Exp Ophthalmol, vol.256, issue.10, p.30069748, 2018.

J. Chen and C. Liu, Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials, J Rheumatol, vol.33, issue.4, pp.722-753, 2006.

Q. Qiu, J. Huang, and L. , Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis, Medicine (Baltimore), vol.96, issue.11, p.6337, 2017.

P. M. Brown, A. G. Pratt, and J. D. Isaacs, Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers, Nat Rev Rheumatol, vol.12, issue.12, pp.731-742, 2016.

D. Wendling, A. Joshi, and P. Reilly, Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database, Curr Med Res Opin, vol.30, pp.2515-2521, 2014.

M. M. Ward, A. Deodhar, and E. A. Akl, American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis, Arthritis Rheumatol, vol.68, pp.282-298, 2016.

A. D. Dick, J. T. Rosenbaum, and A. Ha, Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative. Ophthalmology, vol.125, pp.758-774, 2018.

Y. Jamilloux, D. Saadoun, P. Sève, . ;-re, and . Dick, Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS, vol.125, pp.757-773, 2018.

J. Zochling, TNF-alpha inhibitors for ankylosing spondylitis, Cochrane Database Syst Rev, vol.18, issue.4, p.5468, 2015.